Cancer Research Institute: Clinical Innovator
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $1,000,000 US.
Disciplines:
- Health Sciences
Sponsors:
Deadlines:
Internal Deadline:
December 1, 2024Sponsor Deadline:
May 1, 2025Additional Dates:
- Protocol HRS Due Date: ASAP -
- Protocol Sponsor Due Date - December 1, 2024
- Application Sponsor Due Date (by invitation) - May 1, 2025
Description:
This grant funds clinician-scientists launching innovative phase I/II clinical studies with novel immunotherapies, focusing on novelty, feasibility, clinical impact, and mechanistic insights for biomarker discovery.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.